Authors


Jessica Chow, MD

Latest:

Cyclosporine for dry eye associated with anti-PD-1 therapy

Topical cyclosporine may be useful for treating dry eyes associated with immunomodulatory agents like nivolumab, which markedly upregulate T cell activation. In caring for patients with ocular side effects associated with cancer treatment, the delivery of proper ophthalmic care is critical.


Steve Lenier

Latest:

Assessing the severity of Fuchs’ endothelial corneal dystrophy by using Scheimpflug tomography

Investigators sought to develop a severity scale for tomographic edema in FECD based on Scheimpflug tomography maps, and to evaluate intra- and inter-observer variation for assessing severity.


Bryan S. Lee, MD, JD

Latest:

Integrating computer-assisted toric IOL implantation

Since making the switch to a markerless toric alignment system, Bryan S. Lee, MD, JD, explains how the technology has eliminated ink marking from his surgical regimen.


Lekha Mukkamala, MD

Latest:

Irritation in a bottle: Glaucoma and OSD

OSD is of significant concern in patients with glaucoma on multiple topical medications. Optimal treatment of this condition with minimizing the intensity as well as with additional pharmacologic treatments for OSD can improve visual acuity and compliance and result in better outcomes both medically and regarding patient satisfaction.


Albert S. Khouri, MD

Latest:

Irritation in a bottle: Glaucoma and OSD

OSD is of significant concern in patients with glaucoma on multiple topical medications. Optimal treatment of this condition with minimizing the intensity as well as with additional pharmacologic treatments for OSD can improve visual acuity and compliance and result in better outcomes both medically and regarding patient satisfaction.


David W. Evans, PhD, MBA

Latest:

Let's be social: Making Facebook connections work

One mistake ophthalmologists typically make with Facebook is to presume their practice websites and Facebook pages should contain similar information. Another misperception is that Facebook is a platform for the constant promotion of their specials, procedures, or new technologies in eye care.


Erin Murphy

Latest:

Work of eye bank network shows far-reaching impact

In 2016, Vision Share eye banks provided more than half the supply of U.S. donor corneas with over 20,000 placements. It has worked to build the largest network of non-profit eye banks in the world, with 13 members and 20 eye banks in the United States and a vast network of providers at home and abroad.


William N. May, MD

Latest:

Don’t practice what I preach

Recent surveys across most medical specialties confirm physicians in active practice preach to themselves and their patients about the fulfillment of providing intimate, life-improving care, but advise their children to avoid becoming physicians.


Elizabeth Yeu, MD

Latest:

Study offering new hope for medical presbyopia correction

BRIO-1 clinical trial sowing optimism as a potential therapeutic option.


José Luis Güell, MD

Latest:

Micro-instrumentation reduces trauma in IOL exchange

Increased procedure volume and patient expectations have made IOL exchange procedures more common. Smaller incisions and the need to reduce trauma require new micro-instrumentation for best outcomes.


Kim Wise, MD

Latest:

Unconventional times

Whether one agrees or disagrees with President Donald J. Trump, we can agree that part of his success was finding a way to skip the media, go around the career politicians, and go directly to the people. Is it possible that our legislative efforts have borne so little fruit because we’ve approached it as a politician would?


William Bond, MD

Latest:

How pattern, flicker ERG can impact cataract treatment decisions

Retinal issues can impact cataract surgery outcomes, especially for those with multifocal or other premium lenses. While multifocal lenses may allow the patient to see more clearly across a range of distances, they may also decrease the amount of light that reaches the retina, exacerbating any issues that may already be present.


Caroline Richards

Latest:

The need for precision management in glaucoma moves field forward

Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and adverse effects. Recent research efforts are exploring modifiable risk factors such as caffeine consumption.


Steven D. Vold, MD; Special to Ophthalmology Times

Latest:

Early surgical intervention with stent advantageous for certain glaucomas

It is well known that with most disease, the earlier it is detected, the better the outcome prognosis. Along with early detection comes the need for early treatment. Traditionally, options for glaucoma have been limited. Medications can be effective when used properly, though patients are notorious for compliance issues.


Andrij Savich

Latest:

Laser trabeculoplasty suitable for all open-angle glaucoma patients

Prostaglandin-based topical therapy has been the ‘go-to treatment’ for open-angle glaucoma for decades. In contrast, laser trabeculoplasty has conventionally remained reserved for patients unresponsive or unable to adhere to medication-based therapy.


Dr Paolo Fazio

Latest:

The importance of being honest

One of the biggest challenges for ophthalmologists, especially in the field of refractive surgery, is to define ourselves (in professional terms) and set our goals.



Mark J. Gallardo, MD

Latest:

ABiC viable option for different stages severities of glaucoma

With its ability to restore the eye’s natural outflow pathway, ab-interno canaloplasty (ABiC) presents a viable option for the treatment of different stages and severities of glaucoma, according to Mark J. Gallardo, MD.


Juan Carlos Izquierdo, MD

Latest:

Flexible glaucoma procedure serves wide variety of patients

Juan Carlos Izquierdo, MD, decribes how CO2 laser-assisted sclerectomy surgery is a successful, less invasive, and more simple option for a wide range of glaucoma patients. Due to his overall success with the CLASS procedure, he no longer performs trabeculectomy.


Sumit “Sam” Garg, MD

Latest:

PANTHER Study offers 1-year results for fluocinolone acetonide intravitreal implant

The study investigates 3-year intravitreal implant in eyes with active noninfectious posterior uveitis.


Blake K. Williamson, MD

Latest:

Adding electroretinography: Technology to clinical utility

Pattern electroretinography (PERG) and visually evoked potential (VEP) tests can objectively evaluate the function of axion and retinal ganglion cells. These test results can add another component in successfully treating patients with cataract and/or glaucoma.


Sidd Chopra

Latest:

Why ophthalmologists are easy prey for cybercriminals

A perfect storm is brewing that may make ophthalmologists and office staff, with networked equipment, easy targets for cyber criminals. In a matter of days, cyber criminals can infect computers around the world. Sure, you can pay the ransom, but HIPAA fines and consultant fees, recovering from the damage to your reputation, loss of patients, and all the time and energy lost could bankrupt your practice.


Louis Kartsonis MD

Latest:

Did JFK back pain cost his life?

On Oct. 26, the federal government will release the last of the secret records on the Kennedy Assassination. Whatever revelations emerge from the estimated 3,600 files, one signature fact will remain: Lee Harvey Oswald was the lone gunman in Dealey Plaza. Still, new perspectives on the tragedy continue to surface, even after 50 years.


Robert B. Nelson, PA-C

Latest:

Integrating new technology into busy ophthalmic ASC

Adopting new technologies across multiple practices using a single ambulatory surgery center can be challenging. A systematic approach leverages technology champions, employs consistent communications, and provides administrative support to secure reimbursement.


Preeya K Gupta MD

Latest:

Tear osmolarity: Dry eye's 'vital sign'

Hyperosmolarity emerges as key mechanism in TFOS DEWS II pathophysiology report


Amy Coburn MD

Latest:

Is your clinic prepared for the next natural disaster?

When natural disasters strike, ophthalmologists can play a critical role in recovery through disaster response plans that maintain and restore clinic and hospital operations and provide outreach to the community.


Adam S. Friend, MD

Latest:

Four ocular surface health questions to consider before cataract surgery

A thorough investigation of ocular surface health and initiation of any necessary treatment is the first step toward successful cataract surgery.


Hilary A Beaver MD

Latest:

Is your clinic prepared for the next natural disaster?

When natural disasters strike, ophthalmologists can play a critical role in recovery through disaster response plans that maintain and restore clinic and hospital operations and provide outreach to the community.


James McLaughlin

Latest:

New metrics, new therapies for dry eye

Recently, there has been a greater interest in metrics focused upon the impact of dry eye disease on everyday activities such as reading, driving, or use of various visual display devices. These efforts provide a “real-life” assessment of how dry eye disease impacts vision-related activities.


Gail Torkildsen, MD

Latest:

Surveying the artificial tear landscape

Patients use artificial tears for different reasons and diverse conditions. While available products supplement tear production and provide relief, few distinctions between drops have been clearly established. Recent studies show that direct comparison of a new product to an older, established one and use of “real-world” metrics can be most useful to prescribers.

© 2024 MJH Life Sciences

All rights reserved.